效应器
CD8型
生物
细胞毒性T细胞
癌症研究
免疫疗法
T细胞
嵌合抗原受体
免疫系统
结直肠癌
免疫学
免疫
受体
T细胞受体
细胞
干扰素
信号转导
抗原
调节性T细胞
癌症免疫疗法
医学
激酶
细胞疗法
细胞因子
CTL公司*
作者
Andrea Castiglioni,Andrea Monestiroli,Gloria Delfanti,Paola Zordan,Cristina Giordano,Leonardo Andreoni,Barbara Clissi,Charlotte Blanche Ekalle-Soppo,Lorena Maria Ferreira,Francesca Caruso,Valentina Buttiglione,Iris Stefanetta,Federica Pedica,Claudio Doglioni,Federica Cipriani,Francesca Ratti,Ugo Elmore,Riccardo Rosati,Chiara Gnasso,Antonio Esposito
出处
期刊:Science Advances
[American Association for the Advancement of Science]
日期:2026-11-04
卷期号:12 (45): eaei0181-eaei0181
标识
DOI:10.1126/sciadv.aei0181
摘要
Colorectal cancer liver metastases (CRC-LMs) are associated with poor survival and frequently resist immunotherapy, yet the mechanisms underlying this immune refractoriness remain incompletely defined. Here, we identify a tumor-intrinsic type I interferon (IFN-I)–high state in CRC-LMs associated with loss of the IFN-α/β receptor subunit 1 (IFNAR1) on effector T lymphocytes within immune-enriched perimetastatic niches. Reduced IFNAR1 expression stratifies patients with poor clinical outcomes. Transcriptional profiling of patient-derived organoids and complementary preclinical models revealed heterogeneous but recurrent tumor-derived IFN-I production in CRC-LMs. In IFN-I high contexts, sustained signaling promoted IFNAR1 internalization on effector CD8 + T cells, impairing their persistence, survival, and effector function. Pharmacologic or genetic stabilization of IFNAR1 on cell surface restored CD8 + T cell fitness and selectively enhanced T cell receptor– and chimeric antigen receptor–based immunotherapies in IFN-I high tumors. These findings define a context-dependent IFN-I high / IFNAR1 low axis that constrains antitumor immunity in CRC-LMs and identify IFNAR1 stabilization as a strategy to convert chronic IFN signaling from a suppressive barrier into a therapeutic vulnerability.
科研通智能强力驱动
Strongly Powered by AbleSci AI